Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Validation of Blister Packaging Operations

Posted on By

SOP for Validation of Blister Packaging Operations

Standard Operating Procedure for Validating Blister Packaging Operations

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the process for validating blister packaging operations for pharmaceutical products, including tablets, capsules, and other solid dosage forms. The validation ensures that the blister packaging process consistently meets required product specifications, such as blister integrity, label accuracy, and seal quality. This SOP guarantees that packaging is done efficiently and securely, preventing contamination and ensuring the product’s safety and compliance with regulatory standards.

2) Scope

This SOP applies to the validation of blister packaging operations for solid dosage forms, including both manual and automated blister packaging machines. It covers all stages of the blister packaging process, from feeding tablets or capsules into the blister cavity, to sealing the blister, labeling, and inspecting for defects. The SOP ensures that all critical process parameters such as blister formation, seal integrity, and label placement are validated to meet regulatory and product specifications. This SOP is applicable to new products and those undergoing changes in packaging or formulation.

3) Responsibilities

Operators: Responsible for operating the blister packaging equipment according to the approved protocol and ensuring that all critical process parameters are followed and documented.
Quality Assurance (QA): Ensures that the blister packaging process is validated in compliance with this SOP and meets all regulatory requirements. QA is also responsible for reviewing and approving all validation reports and documentation.
Production Supervisors: Oversee the blister packaging process and ensure that operators follow all required procedures, ensuring that the process is conducted according to the approved protocol.
Validation Team: Responsible for developing the blister packaging process validation protocol, executing the validation runs, and analyzing the results.
Maintenance Personnel: Ensures that all blister packaging equipment, including feeders, forming dies, sealing units, and labeling machines, are calibrated and maintained during the validation process.

See also  SOP for Validation of Dissolution Testing for Tablets and Capsules

4) Procedure

The following steps should be followed for the validation of blister packaging operations:

1. Preparation for Validation:
1.1 Review batch records, product specifications, and regulatory guidelines to identify critical process parameters (CPPs) for the blister packaging process, such as blister integrity, seal quality, and labeling accuracy.
1.2 Develop a process validation protocol that includes the objectives, scope, equipment, process flow, and personnel involved in the validation process.
1.3 Ensure that all blister packaging equipment, including sealing machines, feeders, and labeling systems, are calibrated and operational before initiating the validation process.

2. Validation Protocol:
2.1 Protocol Design: The validation protocol should be designed based on the specific blister packaging equipment and the product being packaged. It should outline the steps to verify fill weight, blister integrity, seal quality, and labeling accuracy.
2.2 Defining Acceptance Criteria: Establish acceptance criteria for critical parameters such as fill weight, blister seal integrity, label placement accuracy, and packaging speed. Criteria should include allowable tolerances for seal defects, labeling errors, and production speed.
2.3 Risk Assessment: Perform a risk assessment to identify critical quality attributes (CQAs) and corresponding critical process parameters (CPPs). This helps ensure that risks related to blister packaging failures, such as damaged seals or incorrect labels, are minimized during the validation process.

3. Execution of Validation:
3.1 Blister Packaging Equipment Setup: Set up the blister packaging equipment according to the specified parameters, ensuring that the correct blister cavity, sealing settings, and label placement are configured.
3.2 Feeding and Positioning: Load the tablets, capsules, or other dosage forms into the blister cavities. Ensure that the correct number of units are fed and positioned properly before sealing.
3.3 Sealing Process Monitoring: Monitor the sealing process to ensure that the seal is properly formed and that the blister cavities are securely closed. Verify that no defects such as partial seals, open blisters, or contamination are present.
3.4 Labeling Inspection: Perform labeling accuracy checks to ensure that labels are correctly placed and contain the right information, such as batch numbers, expiry dates, and dosage instructions. Perform sampling to confirm label placement and legibility.
3.5 Inspection for Packaging Defects: Conduct visual inspections to ensure that there are no defects in the blister packs, such as misalignment, torn packaging, or improperly sealed blisters. Perform tests on a sample of blister packs to confirm that packaging quality meets product specifications.
3.6 Packaging Speed Monitoring: Monitor the packaging speed during the process to ensure it remains within the defined range and does not affect packaging quality. Record production rates and verify that the process can achieve the desired throughput without compromising quality.

See also  SOP for Qualification of Mixing Tanks with Agitators

4. Documentation and Reporting:
4.1 Record all data during the validation process, including batch records, equipment logs, process parameters, and test results for seal integrity, labeling accuracy, and packaging speed.
4.2 Ensure that all forms, reports, and certificates are completed and signed by the responsible personnel.
4.3 Perform statistical analysis of the collected data to assess the consistency and capability of the blister packaging process. This analysis should confirm that the process consistently produces products that meet the acceptance criteria for fill weight, seal quality, and labeling accuracy.
4.4 Prepare a final validation report summarizing the results of the validation, including any deviations, corrective actions, and conclusions regarding the blister packaging process.

See also  SOP for Cleaning Validation of Filter Assemblies

5. Revalidation:
5.1 Revalidate the blister packaging process if there are significant changes to the formulation, packaging equipment, or critical process parameters.
5.2 Periodically conduct revalidation to ensure continued compliance with regulatory requirements and confirm that the blister packaging process consistently produces high-quality products.

5) Abbreviations

  • QA: Quality Assurance
  • CPP: Critical Process Parameter
  • CQA: Critical Quality Attribute
  • SOP: Standard Operating Procedure
  • HPLC: High Performance Liquid Chromatography

6) Documents

  • Process Validation Protocol
  • Batch Production Records
  • Equipment Calibration Logs
  • Blister Packaging Process Validation Reports
  • Seal Integrity Test Records
  • Labeling Inspection Records
  • Packaging Speed Monitoring Logs

7) Reference

  • FDA Guidance for Industry: Process Validation
  • International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • ISO 9001: Quality Management Systems – Requirements
  • USP Chapter 1151: Pharmaceutical Dosage Forms

8) SOP Version

Version 1.0 – Effective Date: DD/MM/YYYY

Annexure

Template 1: Blister Packaging Process Record

Date Time Operator Initials Fill Weight (g) Seal Integrity Test Result Packaging Speed (units/min)
DD/MM/YYYY HH:MM Operator Name Weight in g Pass/Fail Speed in units/min
           

Template 2: Labeling Inspection Record

Batch No. Inspection Date Labeling Accuracy Pass/Fail Operator Initials
Batch Number DD/MM/YYYY Pass/Fail Pass/Fail Operator Name
         

Template 3: Packaging Speed Monitoring Record

Batch No. Test Date Speed (units/min) Production Time (minutes) Operator Initials
Batch Number DD/MM/YYYY Speed in units/min Production time in minutes Operator Name
         
Validations and Qualifications Tags:Cleaning Validation in Pharmaceutical Industry, Computer System Validation in Pharma, Computer System Validation in Pharmaceuticals, Define Validation in Pharma, Equipment Qualification in Pharma, Method Validation in Pharma, Performance Qualification in Pharma, Pharma Validation, Pharmaceutical Cleaning Validation, Pharmaceutical Method Validation, Pharmaceutical Process Validation, Pharmaceutical Process Validation SOP, Pharmaceutical Validation Definition, Pharmaceutical Validation Services, Process Validation Definition in Pharma, Process Validation in Pharma, Process Validation in Pharma Industry, Process Validation in Pharmaceutical Industry, Prospective Validation in Pharma, Qualification in Pharma, Software Validation in Pharmaceutical Industry, SOP for Analytical Method Validations, SOP for Cleaning Validations, SOP for Equipment Validations, SOP for Process Validation, SOP for Validations, Types of Validation in Pharma, Types of Validation in Pharmaceutical Industry, Validation in Pharmaceutical Industry, Validation Life Cycle in Pharma

Post navigation

Previous Post: SOP for Validation of Packaging Processes for Solid Dosage Forms
Next Post: SOP for In Silico Docking Studies

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version